In a comparative clinical trial of primary versus lymph node metastatic tumours, Csanadi et al. found a positive correlation between SLC1A5 expression and corresponding lymph node metastasis. This evidence concerns the gene SLC1A5 and metastatic malignant neoplasm in the lymph nodes.